Water dispersible microbicidal cellulose acetate phthalate film
Open Access
- 14 November 2003
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 3 (1) , 27
Abstract
Cellulose acetate phthalate (CAP) has been used for several decades in the pharmaceutical industry for enteric film coating of oral tablets and capsules. Micronized CAP, available commercially as "Aquateric" and containing additional ingredients required for micronization, used for tablet coating from water dispersions, was shown to adsorb and inactivate the human immunodeficiency virus (HIV-1), herpesviruses (HSV) and other sexually transmitted disease (STD) pathogens. Earlier studies indicate that a gel formulation of micronized CAP has a potential as a topical microbicide for prevention of STDs including the acquired immunodeficiency syndrome (AIDS). The objective of endeavors described here was to develop a water dispersible CAP film amenable to inexpensive industrial mass production. CAP and hydroxypropyl cellulose (HPC) were dissolved in different organic solvent mixtures, poured into dishes, and the solvents evaporated. Graded quantities of a resulting selected film were mixed for 5 min at 37°C with HIV-1, HSV and other STD pathogens, respectively. Residual infectivity of the treated viruses and bacteria was determined. The prerequisites for producing CAP films which are soft, flexible and dispersible in water, resulting in smooth gels, are combining CAP with HPC (other cellulose derivatives are unsuitable), and casting from organic solvent mixtures containing ≈50 to ≈65% ethanol (EtOH). The films are ≈100 µ thick and have a textured surface with alternating protrusions and depressions revealed by scanning electron microscopy. The films, before complete conversion into a gel, rapidly inactivated HIV-1 and HSV and reduced the infectivity of non-viral STD pathogens >1,000-fold. Soft pliable CAP-HPC composite films can be generated by casting from organic solvent mixtures containing EtOH. The films rapidly reduce the infectivity of several STD pathogens, including HIV-1. They are converted into gels and thus do not have to be removed following application and use. In addition to their potential as topical microbicides, the films have promise for mucosal delivery of pharmaceuticals other than CAP.Keywords
This publication has 46 references indexed in Scilit:
- Involvement of Lipids in Different Steps of the Flavivirus Fusion MechanismJournal of Virology, 2003
- Recent Herpes Simplex Virus Type 2 Infection and the Risk of Human Immunodeficiency Virus Type 1 Acquisition in IndiaThe Journal of Infectious Diseases, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Entry of Inflammatory Cells Into the Mouse Vagina Following Application of Candidate MicrobicidesSexually Transmitted Diseases, 2002
- A Systematic Review of the Epidemiologic Interactions Between Classic Sexually Transmitted Diseases and HIVSexually Transmitted Diseases, 2001
- Microbicide for Prevention of Sexually Transmitted Diseases Using a Pharmaceutical ExcipientAIDS Patient Care and STDs, 2000
- Design of a “Microbicide” for Prevention of Sexually Transmitted Diseases Using “Inactive” Pharmaceutical ExcipientsBiologicals, 1999
- Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular ToleranceJournal of Ocular Pharmacology and Therapeutics, 1998
- Abrin to zygadenineTrends in Plant Science, 1997
- Human Immunodeficiency Virus Infection And Other Sexually Transmitted Diseases In Developing Countries: Public Health Importance And Priorities For Resource AllocationThe Journal of Infectious Diseases, 1996